share_log

Morgan Stanley Downgraded RE/MAX Stock, Price Target Slashed By Over 50% — NAR Ruling Key Risk

Morgan Stanley Downgraded RE/MAX Stock, Price Target Slashed By Over 50% — NAR Ruling Key Risk

摩根士丹利下调RE/MAX股票评级,目标股价下调50%以上— NAR裁定关键风险
Benzinga ·  2023/11/07 11:57

The stock of real estate brokerage firm RE/MAX Holdings Inc (NYSE:RMAX), short for Real Estate Maximums, was downgraded to underweight on Nov. 6 by Morgan Stanley (NYSE:MS).

房地产经纪公司的股票 RE/MAX 控股公司 纽约证券交易所代码:RMAX)是房地产最高指数的缩写,于11月6日被下调至减持 摩根士丹利 (纽约证券交易所:MS)。

The investment bank identified the NAR ruling as a key risk.

该投资银行将NAR的裁决确定为关键风险。

"NAR ruling increases risk of further litigation and costly settlements," said the note. Housing strategists at Morgan Stanley expect 2024 to present a challenging backdrop to the company. Accordingly, the firm re-adjusted its EBITDA and EPS expectations, leading to a $10.50 drop in their price target.

该报告说:“NAR的裁决增加了进一步诉讼和昂贵和解的风险。”摩根士丹利的住房策略师预计,2024年将为公司带来充满挑战的背景。因此,该公司重新调整了其息税折旧摊销前利润和每股收益预期,导致其目标股价下跌10.50美元。

The RMAX Analyst: Morgan Stanley analyst Ronald Kamdem, CFA had a revised price target of $9 with an Underweight rating. The firm used a 6.5x multiple, representing a 6% discount to CRE brokers (at 6.9x) and a 34% discount to RMAX 5-year historical average.

RMAX 分析师: 摩根士丹利分析师 Ronald Kamdem,CFA 修改后的目标股价为9美元,评级为减持。该公司使用了6.5倍的倍数,相当于CRE经纪商的6%折扣(6.9倍),比RMAX的5年历史平均水平折扣34%。

The stock was earlier rated Equal-weight with a price target of $19.50.

该股早些时候被评为同等权重,目标股价为19.50美元。

The RMAX Takeaways: Morgan Stanley analysts laid out five risks that could weigh down the stock's multiple:

RMAX 要点: 摩根士丹利分析师列出了五种可能压低该股倍数的风险:

  • The risk of additional litigation and costly settlement
  • Earnings risk , given RMAX's direct exposure to broker fees
  • Limited ability to return capital to shareholders
  • 8% mortgage rate remains an ongoing headwind
  • Management transition at a time of ongoing litigation exposes the firm to execution risk
  • 额外诉讼和昂贵和解的风险
  • 鉴于RMAX直接面临经纪人费用,收益风险
  • 向股东返还资本的能力有限
  • 8%的抵押贷款利率仍然是一个持续的不利因素
  • 在诉讼持续之际,管理层的过渡使公司面临执行风险

RMAX Price Action: RMAX was trading down 10.19% at $9.70 at publication Tuesday.

RMAX 价格走势: 周二公布时,RMAX交易价格下跌10.19%,至9.70美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发